Original article title
A mechanistic pharmacokinetic-patient-derived organoid (PK-PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer.
The source
A source-supported takeaway is not available for this item yet. Open the source for details.
Keep in mind
Preclinical · not proven in patients.
pubmed.ncbi.nlm.nih.gov · Full-text access depends on the publisher.
No conclusion has been invented where the source lacks detail. The original title is preserved above.
This is a reading aid. Follow the source for methods, limitations, corrections, and clinical context.